TrialBritish journal of haematology2009

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.

Kristie A Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.